Cargando…
Multisystem Inflammatory Syndrome in Adult Following COVID-19 Vaccination (MIS-AV)
The last 2 years have been dominated by coronavirus disease-2019 (COVID-19), its various presentations, complications, and their management. The first COVID-19 vaccine, produced by Pfizer-BioNTech, was granted regulatory approval on December 2, 2020, by the UK medicines regulator medicines and healt...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Jaypee Brothers Medical Publishers
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160620/ https://www.ncbi.nlm.nih.gov/pubmed/35719439 http://dx.doi.org/10.5005/jp-journals-10071-24214 |